---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-029239"
form_type: "8-K"
ticker: "ODYS"
cik: "0001577445"
company_name: "Odysight.ai Inc."
filed_at: "2023-08-17T23:59:59+00:00"
generated_at: "2026-06-11T07:41:45.704820+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Odysight.ai appoints Nir Nimrodi to board of directors

## Summary
- Nir Nimrodi appointed to board effective August 13, 2023; board determined independent under Nasdaq rules.
- Nimrodi is chairman & CEO of Accellix Inc., with over 25 years in life sciences, biotech, and pharma.
- Previously served as CBO at Intrexon (Precigen) and VP/GM at Life Technologies (Thermo Fisher).
- He holds an MBA from Tel-Aviv University and will receive standard director fees per prior 10-K.

## SEC filing metadata
- accession: 0001493152-23-029239
- form_type: 8-K
- ticker: ODYS
- cik: 0001577445
- company_name: Odysight.ai Inc.
- filed_at: 2023-08-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1577445/000149315223029239/0001493152-23-029239-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1577445/000149315223029239/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-029239
- JSON: https://secwatch.observer/filing/0001493152-23-029239.json
- Plain text: https://secwatch.observer/filing/0001493152-23-029239.txt

## Key facts
- Executive change
  Nir Nimrodi was appointed as Director at Odysight.ai Inc..
  - Action: appointed
  - Role: Director
  source text: On August 13, 2023, the Board of Directors of Odysight.ai Inc. (the “Board” and the “Company”, respectively) appointed Mr. Nir Nimrodi to serve as a member of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1577445/000149315223029239/0001493152-23-029239-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.